Skip to main content
. 2019 Sep 16;72(3):240–246. doi: 10.5173/ceju.2019.1974

Figure 1A.

Figure 1A

Comparison of prostate-specific antigen (PSA) rates (%) between study groups (* – p = 0.035, # – p = 0.005).